Much of the talk today about the leading edge of clinical MR focuses on 3T scanning and what this new benchmark for high-field imaging can do now and in the future. But with relatively little fanfare, vendors have been installing systems that operate at 7T, exploring new potential and establishing the basis for clinical relevance that may go beyond their use in research.
Much of the talk today about the leading edge of clinical MR focuses on 3T scanning and what this new benchmark for high-field imaging can do now and in the future. But with relatively little fanfare, vendors have been installing systems that operate at 7T, exploring new potential and establishing the basis for clinical relevance that may go beyond their use in research.
As part of this process, investigators from Ohio State University in Columbus and Columbia University in New York City have found that 7T MRI can detect multiple sclerosis lesions better than mainstream MR technologies. This sensitivity, they say, might lead to earlier diagnosis and treatment.
The researchers analyzed postmortem brain slices from an MS patient using both 3T and 7T MRI. The ultrahigh field scan found numerous MS lesions not detectable at the lower field, according to Dr. Steffen Sammet, a postdoctoral researcher in the OSU radiology department. The greater sensitivity of 7T MRI might make the disease easier to diagnose in its early stages, leading possibly to improved monitoring of neurological deficits, he said.
Scanning at 7T might also provide information about the lesion microstructure to provide a better understanding of MS, underscoring the benefits of this technology, which lately has shown signs of evolving from an experimental methodology into one with clinical ramifications.
"The significant advantage of higher field strength is the gain in signal that can be used in many different ways to increase sensitivity and speed of acquisition or to increase resolution," he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.